1De Caterina R, Husted S, Wallentin L, et al. New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC working group on thrombosis-task force on anticoagulants in heart disease position paper.J Am Coli Cardiol, 2012,59: 1413- 1425.
2Van de Werf F, Brueckmann M, Connolly SJ, et al. A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: the randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement (RE-ALIGN). Am HeartJ ,2012 ,163 :931-937.
3PriceJ, Hynes M, Labinaz M, et al. Mechanical valve thrombosis with dabigatran.J Am Coli Cardiol,2012 ,60: 1710-1711.
4Whitlock RP, SunJC, Fremes SE, et al. Antithrombotic and thrombolytic therapy for valvular disease: antithrombotic therapy and prevention of thrombosis, 9th ed , American college of chest physicians evidence-based clinical practice guidelines. Chest, 20 12 ,141(2 Suppl) :e576S-e600S.
